Parsons slashes FY26 guidance after Q2 miss, stock plunges 35%
Parsons Corporation reported a Q2 adjusted loss per share of $0.06 and revenue of $1.576 billion, missing consensus estimates. The company cut FY26 revenue guidance to $6.2-$6.5 billion and adjusted EBITDA to $500-$560 million due to a canceled federal contract and divestitures. Analysts lowered price targets, with Truist Securities citing a valuation discount to peers despite strong book-to-bill ratios.

*this image is generated using AI for illustrative purposes only.
Parsons Corporation (NYSE: PSN) shares plunged 35% following a sharp reduction in its full-year 2026 financial guidance and a weaker-than-expected second-quarter performance. The engineering and construction firm reported an adjusted loss per share of $0.06 for the quarter ended June 30, 2026, missing analyst consensus estimates of $0.76. Revenue came in at $1.576 billion, falling short of the $1.617 billion consensus and declining 1% year over year. The company lowered its FY26 revenue guidance to $6.2-$6.5 billion from $6.5-$6.8 billion and cut adjusted EBITDA guidance to $500-$560 million from $615-$675 million, citing a canceled fixed-price government contract and portfolio divestitures.
The guidance adjustment was disclosed via Form 8-K filed with regulators on July 29, 2026. Management attributed the shortfall to "planned divestitures," "lower pass-through costs," and "federal contract timing." A primary driver was a confidential fixed-price contract that was "canceled by the administration," which had generated $50 million in revenue in the quarter ended November 30, 2025. Chair, President and CEO Carey Smith noted that the company is "basically demobilizing" from this program. Additionally, operating income fell 99% year over year to $1 million due to losses from programs targeted for divestiture and charges related to a joint venture program.
Financial Impact and Operational Shortfalls
The financial deterioration is evident in the latest quarterly results, which underscore the severity of the operational headwinds. Reported adjusted EBITDA for the most recent quarter stood at approximately $42 million, representing a roughly 72% decline year over year. Alongside this operating metric contraction, the company reported a net loss of about $15 million for the period. These figures highlight the immediate impact of the canceled contract and broader timing issues within its federal business lines.
| Metric | Previous Guidance / Prior Period | Revised Guidance / Current Period | Change |
|---|---|---|---|
| FY26 Revenue Guidance | $6.5-$6.8 billion | $6.2-$6.5 billion | Lowered |
| FY26 Adj. EBITDA Guidance | $615-$675 million | $500-$560 million | Down to $115 million |
| Q2 FY26 Revenue | N/A | $1.576 billion | Missed Consensus |
| Q2 FY26 Adj. EPS | N/A | ($0.06) Loss | Missed Consensus |
Despite the headwinds, Parsons witnessed a 24% year-over-year increase in contract awards and a 1.2x book-to-bill ratio for the quarter. The company also highlighted 10% organic revenue growth in the Middle East and a 1.1x book-to-bill ratio in that region, alongside "portfolio-shaping" actions aimed at prioritizing profitable, sustainable growth.
Analyst Reactions and Technical Outlook
Following the earnings release, several analysts trimmed their price forecasts for Parsons. UBS lowered its target to $58.00, Citigroup to $53.00, and Stifel to $66.00, all maintaining Buy ratings. Truist Securities analyst Tobey Sommer reiterated a Buy rating but lowered the price forecast from $75 to $60, citing an 18% cut in EBITDA guidance. Sommer noted that Parsons now trades at an estimated 10% discount to peers, compared to a historical 20% premium, expecting this gap to narrow given exposure to high-priority defense areas.
Technically, PSN remains under pressure, trading 31.7% below its 200-day SMA of $63.37 and 20.9% below the 20-day SMA of $54.76. Key resistance sits at $54.94 (50-day SMA), while key support is at $56.26, the 52-week low zone. The stock’s momentum indicators, including MACD, remain negative, suggesting continued downside risk unless buyers reassert control near support levels.
How will the divestiture of underperforming assets impact Parsons' long-term revenue mix and margin profile once the transition period concludes?
What specific strategies is management implementing to offset the loss of the canceled fixed-price government contract in the remaining quarters of FY26?
Can Parsons sustain its 24% year-over-year growth in new contract awards given the current headwinds in federal spending and timing delays?

































